
DC Attorney General Karl Racine (D) filed a notice of appeal Thursday to revive the antitrust case against Amazon that a judge dismissed earlier this year.
The lawsuit, first filed in 2021, alleges Amazon has used its position as a giant in the e-commerce field to maximize profits at the expense of consumers, third-party sellers and wholesalers. It accuses Amazon of using anticompetitive practices by keeping third-party sellers from offering lower-cost proxies for products elsewhere.
A judge dismissed the case in March in an oral ruling.
“We’re appealing the lower court’s decision because District consumers deserve a fair marketplace that promotes competition, innovation, and choice,” Racine said in a statement. “And we’re filing this appeal because the antitrust laws and the facts are on our side—and on the side of District residents. We look forward to making our case before the Court of Appeals.”
The appeal is Racine’s latest attempt to push the first government-led antitrust case against Amazon forward. In April his office filed a motion asking the court to reconsider the ruling.
The Department of Justice (DOJ) also urged the court to reconsider the decision to dismiss the case. DOJ attorneys wrote in an April filing that if “left uncorrected, the Court’s ruling could jeopardize the enforcement of antitrust law by improperly raising the bar on plaintiffs challenging anticompetitive contractual restraints in the District of Columbia.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas